Koyfin Home > Directory > Health Care > Abiomed Inc > Repurchase of Common Stock

Abiomed Inc Repurchase of Common Stock Chart (ABMD)

Abiomed Inc annual/quarterly Repurchase of Common Stock from 2012 to 2020.
  • Abiomed Inc Repurchase of Common Stock for the quarter ending September 09, 2020 was $-1m a -2,258.77% increase of 24m year over year
  • Abiomed Inc Repurchase of Common Stock for the last 12 months ending September 09, 2020 was $-73m a -40.31% increase of 29m year over year
  • Abiomed Inc Annual Repurchase of Common Stock for 2020 was $-127m a 43.29% decrease of -55m from 2019
  • Abiomed Inc Annual Repurchase of Common Stock for 2019 was $-72m a 71.69% decrease of -51m from 2018
  • Abiomed Inc Annual Repurchase of Common Stock for 2018 was $-20m a 1.04% decrease of 0m from 2017
Other Cash Flow Metrics:
  • Abiomed Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $61m a 6.38% increase of 4m year over year
  • Abiomed Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $30m a 50.21% increase of 15m year over year
  • Abiomed Inc Total Revenue for the quarter ending December 12, 2018 was $201m a 13.03% increase of 26m year over year
View Chart On Koyfin

Quarterly ABMD Repurchase of Common Stock Data

09/2020$-1m
06/2020$-21m
03/2020$-25m
12/2019$-25m
09/2019$-36m
06/2019$-41m
03/2019$-1m
12/2018$-2m
09/2018$-2m
06/2018$-68m

Annual ABMD Repurchase of Common Stock Data

2020$-127m
2019$-72m
2018$-20m
2017$-20m
2016$-7m
2015$-3m
2014$0m
2013$-15m